1. CD20‐Specific Immunoligands Engaging NKG2D Enhance γδ T Cell‐Mediated Lysis of Lymphoma Cells. (27th September 2017) Authors: Peipp, M.; Wesch, D.; Oberg, H.‐H.; Lutz, S.; Muskulus, A.; van de Winkel, J. G. J.; Parren, P. W. H. I.; Burger, R.; Humpe, A.; Kabelitz, D.; Gramatzki, M.; Kellner, C. Journal: Scandinavian journal of immunology Issue: Volume 86:Number 4(2017:Oct.) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTRANODAL DISEASE IS ASSOCIATED WITH SHORTER PROGRESSION‐FREE SURVIVAL AFTER CD19‐CAR T‐CELL THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (17th June 2021) Authors: Bücklein, V.; Blumenberg, V.; Ackermann, J.; Frölich, L.; Winkelmann, M.; Schmidt, C.; Rejeski, K.; Ruzicka, M.; Müller, N.; von Baumgarten, L.; Schöberl, F.; Hildebrandt, M.; Humpe, A.; Kunz, W.; Hoster, E.; von Bergwelt, M.; Subklewe, M. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗